TickerStat.comwe like data

Bioforce Nanosciences Holdings, Inc. (BFNH)

Price$6.10Cached quote
BFNHOTC
Loading local price history

Financial charts

Revenue

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

9 annual periodsNewest to oldest
202520242023202220212020201920182017
Revenue$0$0$0$0——$17,775$16,310$4,500
Gross profit$0$0$0$0——$4,360$4,665$1,255
Gross margin——————24.53%28.60%27.89%
Operating expenses$489,951$490,437$471,953$485,514$501,955$158.4M$50,898$71,405$32,516
Operating income−$489,951−$490,437−$471,953−$485,514——−$46,538−$66,740−$31,261
Operating margin——————−261.82%−409.20%−694.69%
EBITDA−$489,951−$490,437−$471,953−$485,514—————
Net income−$1.3M−$490,437−$471,953−$485,514−$501,955−$158.4M−$46,538−$67,738−$31,261
Net profit margin——————−261.82%−415.32%−694.69%
Basic EPSper basic share-$0.04-$0.02-$0.02-$0.02-$0.02-$9.72$0.00$0.00$0.00
Diluted EPSper diluted share-$0.04-$0.02-$0.02-$0.02-$0.02-$9.72$0.00$0.00$0.00
Review official source filings ↗

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about BFNH yet. Start the conversation.

Write the first post